| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0163-7258(03)00034-2 |
| P698 | PubMed publication ID | 12782241 |
| P50 | author | David Lembo | Q37831430 |
| Marisa Gariglio | Q37841165 | ||
| Giorgio Gribaudo | Q43487852 | ||
| Santo Landolfo | Q58661127 | ||
| P2860 | cites work | Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease | Q78052127 |
| A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant | Q78231630 | ||
| Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs | Q24311713 | ||
| Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains | Q28141501 | ||
| Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS | Q28212716 | ||
| Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis | Q28258721 | ||
| Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis | Q28270729 | ||
| Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP | Q28287589 | ||
| Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication | Q28344246 | ||
| Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus disease | Q28375828 | ||
| Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region | Q28378352 | ||
| Increased susceptibility to cytomegalovirus infection in beige mutant mice | Q28513580 | ||
| The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol | Q29618773 | ||
| In silico structural and functional analysis of the human cytomegalovirus (HHV5) genome. | Q30167995 | ||
| Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host | Q30478992 | ||
| Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes | Q30656734 | ||
| Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly | Q33796667 | ||
| Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis | Q33804044 | ||
| Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression | Q33807009 | ||
| Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant | Q72940232 | ||
| Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial | Q72940234 | ||
| Maternal Cytomegalovirus Infection and Perinatal Transmission | Q72957607 | ||
| Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues | Q73107960 | ||
| T cell proliferative responses to five human cytomegalovirus proteins in healthy seropositive individuals: implications for vaccine development | Q73108034 | ||
| Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women | Q73188476 | ||
| Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus | Q73209433 | ||
| Vaccination of seropositive subjects with CHIRON CMV gB subunit vaccine combined with MF59 adjuvant for production of CMV immune globulin | Q73584139 | ||
| Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection | Q73812485 | ||
| Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs | Q73819129 | ||
| A subset of viral transcripts packaged within human cytomegalovirus particles | Q73943063 | ||
| Transmission of cytomegalovirus to preterm infants through breast milk | Q74195690 | ||
| Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women | Q74487211 | ||
| Treatment of cytomegalovirus diseases | Q74802687 | ||
| Monitoring of human cytomegalovirus infections in pediatric bone marrow transplant recipients by nucleic acid sequence-based amplification | Q77437136 | ||
| Domain mapping of the human cytomegalovirus IE1-72 and cellular p107 protein-protein interaction and the possible functional consequences | Q77834230 | ||
| Human cytomegalovirus stimulates cellular dihydrofolate reductase activity in quiescent cells | Q77960081 | ||
| A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects | Q40819262 | ||
| Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. | Q40900792 | ||
| Cell types involved in replication and distribution of human cytomegalovirus. | Q40958077 | ||
| Structure of the human cytomegalovirus B capsid by electron cryomicroscopy and image reconstruction | Q40975733 | ||
| Advances in the management of AIDS-related cytomegalovirus retinitis | Q41014142 | ||
| Human cytomegalovirus infection results in altered Cdk2 subcellular localization | Q41097052 | ||
| The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells | Q33809143 | ||
| The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10) | Q33825616 | ||
| Cytomegalovirus infections in heart and heart and lung transplant recipients | Q33839231 | ||
| Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent | Q33852869 | ||
| Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus | Q33856623 | ||
| Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs | Q33870381 | ||
| Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway | Q33957986 | ||
| Effect of the human cytomegalovirus IE86 protein on expression of E2F-responsive genes: a DNA microarray analysis | Q34014646 | ||
| Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains | Q34063490 | ||
| Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation | Q34191791 | ||
| Do pathogens accelerate atherosclerosis? | Q34389205 | ||
| Development of a cytomegalovirus vaccine: lessons from recent clinical trials | Q34451960 | ||
| Manipulation of the cell cycle by human cytomegalovirus | Q34486186 | ||
| Herpesvirus assembly and egress | Q34499618 | ||
| A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS. | Q34522196 | ||
| vMIA, a viral inhibitor of apoptosis targeting mitochondria | Q34648862 | ||
| Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion | Q34731393 | ||
| Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle | Q35079311 | ||
| Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria | Q35113383 | ||
| Reducing the Risk for Transfusion-transmitted Cytomegalovirus Infection | Q35224651 | ||
| The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products | Q35553472 | ||
| Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters | Q35845633 | ||
| UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells | Q35847129 | ||
| Proteins associated with purified human cytomegalovirus particles | Q35868126 | ||
| Effect of a modulator deletion on transcription of the human cytomegalovirus major immediate-early genes in infected undifferentiated and differentiated cells. | Q35876849 | ||
| Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle | Q35886438 | ||
| pIRS1 and pTRS1 are present in human cytomegalovirus virions | Q35889230 | ||
| Human cytomegalovirus latent infection of granulocyte-macrophage progenitors | Q35945151 | ||
| Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells | Q36013335 | ||
| Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. | Q36295396 | ||
| The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate | Q36310746 | ||
| The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains | Q36398843 | ||
| Cytomegalovirus encodes a potent alpha chemokine | Q36436978 | ||
| A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation | Q36525307 | ||
| Molecular evolution of herpesviruses: genomic and protein sequence comparisons | Q36630244 | ||
| Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site | Q36680389 | ||
| Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2 | Q36690662 | ||
| Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays | Q36736217 | ||
| The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site | Q36796246 | ||
| Human cytomegalovirus origin of DNA replication (oriLyt) resides within a highly complex repetitive region | Q37051574 | ||
| Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients. | Q37095025 | ||
| A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation | Q37248409 | ||
| Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen | Q37265499 | ||
| Stimulation of Cellular Thymidine Kinases by Human Cytomegalovirus | Q37506960 | ||
| E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection | Q38325725 | ||
| Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification. | Q39467685 | ||
| Epidemiology and transmission of cytomegalovirus | Q39496031 | ||
| Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. | Q39591457 | ||
| Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts. | Q39593607 | ||
| Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. | Q39595809 | ||
| Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes | Q39602194 | ||
| Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication | Q39606506 | ||
| The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation | Q39714707 | ||
| A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate | Q39868666 | ||
| Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. | Q39872953 | ||
| Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recov | Q39873608 | ||
| Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters | Q39879958 | ||
| Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins | Q40023788 | ||
| Clinical Trials of Immunization with the Towne 125 Strain of Human Cytomegalovirus | Q40027641 | ||
| Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir. | Q40038190 | ||
| Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain | Q40048677 | ||
| Congenital Cytomegalovirus Infection Outcome for the Subsequent Sibling | Q40057279 | ||
| Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus. | Q40066404 | ||
| The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. | Q40066427 | ||
| Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. | Q40203314 | ||
| Stimulation of Ornithine Decarboxylase by Human Cytomegalovirus | Q40211650 | ||
| Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study Group. | Q40284739 | ||
| Human cytomegalovirus infection induces cellular thymidylate synthase gene expression in quiescent fibroblasts | Q40685620 | ||
| Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study | Q40722026 | ||
| A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation | Q40734820 | ||
| Characterization of the signal peptide processing and membrane association of human cytomegalovirus glycoprotein O. | Q40786177 | ||
| Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. | Q40792295 | ||
| Vaccines against human cytomegalovirus: time to test | Q41125679 | ||
| Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. | Q41163429 | ||
| Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells | Q41179572 | ||
| Reduced Congenital Cytomegalovirus (CMV) Infection after Maternal Immunization with a Guinea Pig CMV Glycoprotein before Gestational Primary CMV Infection in the Guinea Pig Model | Q41277274 | ||
| Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation | Q41343480 | ||
| Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response | Q41390404 | ||
| Human cytomegalovirus cell tropism and pathogenesis | Q41454454 | ||
| Regulation of human cytomegalovirus immediate-early gene expression | Q41454468 | ||
| Structure and assembly of the virion | Q41454502 | ||
| Human cytomegalovirus glycoproteins | Q41454511 | ||
| Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells | Q41761147 | ||
| Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir | Q41844745 | ||
| Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patients | Q41863253 | ||
| Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome | Q41903328 | ||
| The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. | Q41946457 | ||
| The 72K IE1 and 80K IE2 proteins of human cytomegalovirus independently trans-activate the c-fos, c-myc and hsp70 promoters via basal promoter elements | Q42452064 | ||
| Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS. | Q42544020 | ||
| Murine cytomegalovirus infection induces cellular folylpolyglutamate synthetase activity in quiescent cells. | Q42826380 | ||
| Antibodies to Recombinant-Derived Glycoprotein B after Natural Human Cytomegalovirus Infection Correlate with Neutralizing Activity | Q43517822 | ||
| Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients | Q43622689 | ||
| Optimization of DNA immunization against human cytomegalovirus | Q43654256 | ||
| Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors | Q43769307 | ||
| Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy | Q43774416 | ||
| Treatment of AIDS-Associated Gastrointestinal Cytomegalovirus Infection with Foscarnet and Ganciclovir: A Randomized Comparison | Q43819979 | ||
| High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy | Q43833983 | ||
| Glomerulopathy Associated with Cytomegalovirus Viremia in Renal Allografts | Q43927416 | ||
| Asymptomatic primary cytomegalovirus infection: virologic and immunologic features | Q44042219 | ||
| Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. | Q44090097 | ||
| Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes | Q44443155 | ||
| High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: the importance of the gB protein in HCMV immunity | Q44815832 | ||
| A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). | Q44862952 | ||
| Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization | Q44993083 | ||
| Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity | Q45018903 | ||
| Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. | Q45084505 | ||
| Safety and immunogenicity of the Towne strain cytomegalovirus vaccine | Q45110668 | ||
| Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants | Q45163630 | ||
| A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDS. | Q45234692 | ||
| The Structure of the Human Placenta: Implications for Initiating and Defending Against Virus Infections | Q45748518 | ||
| Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial | Q45855440 | ||
| Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group | Q45874436 | ||
| Cytomegalovirus (CMV) infection, CD4+ lymphocyte counts and the development of AIDS in HIV-1-infected haemophiliac patients | Q45879086 | ||
| Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention. | Q46018859 | ||
| Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate | Q46056201 | ||
| Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge | Q46111260 | ||
| Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group | Q46142060 | ||
| Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection | Q46154428 | ||
| Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys | Q46363870 | ||
| A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group | Q46524764 | ||
| High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes | Q46794285 | ||
| Correlation of quantitative human cytomegalovirus pp65-, p72- and p150-antigenemia, viremia and circulating endothelial giant cells with clinical symptoms and antiviral treatment in immunocompromised patients. | Q47968618 | ||
| Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection | Q47980476 | ||
| Immune evasion by cytomegalovirus--survival strategies of a highly adapted opportunist. | Q48009213 | ||
| Analysis of Interstrain Variation in Cytomegalovirus Glycoprotein B Sequences Encoding Neutralization-Related Epitopes | Q48224220 | ||
| Human cytomegalovirus encodes three G protein-coupled receptor homologues | Q48269680 | ||
| A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus | Q48378635 | ||
| Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis | Q50132411 | ||
| The outcome of congenital cytomegalovirus infection in relation to maternal antibody status | Q50539344 | ||
| Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero. | Q52116864 | ||
| Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. | Q54038587 | ||
| Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group. | Q54145038 | ||
| Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay. | Q54261492 | ||
| The human cytomegalovirus UL100 gene encodes the gC-II glycoproteins recognized by group 2 monoclonal antibodies. | Q54624350 | ||
| Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease | Q57181650 | ||
| Polymerase chain reaction for prenatal diagnosis of congenital human cytomegalovirus infection | Q57275317 | ||
| Human Cytomegalovirus Immediate‐Early Messenger RNA in Blood of Pregnant Women with Primary Infection and of Congenitally Infected Newborns | Q58381826 | ||
| Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus | Q58474169 | ||
| Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product | Q59098221 | ||
| Congenital cytomegalovirus infection | Q66846585 | ||
| Preemptive Therapy in Immunocompromised Hosts | Q67914367 | ||
| Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia | Q68248914 | ||
| Cytomegalovirus Retinopathy as the Initial Manifestation of the Acquired Immunodeficiency Syndrome | Q68251682 | ||
| A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS | Q68259005 | ||
| Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation | Q68262204 | ||
| Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient | Q68299259 | ||
| Cytomegalovirus is frequently isolated in bronchoalveolar lavage fluid of bone marrow transplant recipients without pneumonia | Q68459962 | ||
| Maternal cytomegalovirus excretion and perinatal infection | Q68661799 | ||
| Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group | Q69370235 | ||
| Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients | Q69807975 | ||
| Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome | Q69827205 | ||
| Antibodies to human cytomegalovirus structural polypeptides during primary infection | Q69848231 | ||
| Histopathology of early and late human hepatic allograft rejection: evidence of progressive destruction of interlobular bile ducts | Q69917951 | ||
| Cytomegalovirus glomerulopathy: a controversial lesion | Q70138483 | ||
| Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome | Q70148540 | ||
| Specific Cell-Mediated Immunity and the Natural History of Congenital Infection with Cytomegalovirus | Q70180828 | ||
| Tissue macrophages are infected by human cytomegalovirus in vivo | Q70826656 | ||
| Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients | Q70883328 | ||
| Susceptibility of human cytomegalovirus to cidofovir is unchanged after limited in vivo exposure to various regimens of drug | Q71007524 | ||
| Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo | Q71071690 | ||
| Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group | Q71965473 | ||
| Potential role of human cytomegalovirus and p53 interaction in coronary restenosis | Q72041267 | ||
| Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor | Q72059554 | ||
| Molecular analysis of the immune response to human cytomegalovirus glycoprotein B. I. Mapping of HLA-restricted helper T cell epitopes on gp93 | Q72098369 | ||
| Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates | Q72351476 | ||
| Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants | Q72573704 | ||
| Analysis of the proliferative T cell response to human cytomegalovirus major immediate-early protein (IE1): phenotype, frequency and variability | Q72580508 | ||
| Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci | Q72593822 | ||
| The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulatio | Q72696029 | ||
| High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial | Q72765106 | ||
| P433 | issue | 3 | |
| P921 | main subject | Cytomegalovirus | Q6946 |
| P304 | page(s) | 269-297 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Pharmacology & Therapeutics | Q3378596 |
| P1476 | title | The human cytomegalovirus | |
| P478 | volume | 98 |
| Q30435694 | A Cmv2 QTL on chromosome X affects MCMV resistance in New Zealand male mice |
| Q33648958 | A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells |
| Q92091394 | Activation of 6-Alkoxy-Substituted Methylenecyclopropane Nucleoside Analogs Requires Enzymatic Modification by Adenosine Deaminase-Like Protein 1 |
| Q40147737 | Activation of the virus-induced IKK/NF-kappaB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells. |
| Q42201836 | Agmatine-containing poly(amidoamine)s as a novel class of antiviral macromolecules: structural properties and in vitro evaluation of infectivity inhibition |
| Q43139388 | Analysis of colorectal cancers for human cytomegalovirus presence. |
| Q27755387 | Approved Antiviral Drugs over the Past 50 Years |
| Q26744665 | Bioactive Molecules Released From Cells Infected with the Human Cytomegalovirus |
| Q40607067 | CTCF binding to the first intron of the major immediate early (MIE) gene of human cytomegalovirus (HCMV) negatively regulates MIE gene expression and HCMV replication |
| Q84549550 | Cellular signals involved in cyclooxygenase-2 expression induced by human cytomegalovirus |
| Q33221784 | Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus |
| Q36423984 | Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. |
| Q34743747 | Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells |
| Q37123419 | Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH/gL/gO and gH/gL/UL128-131 in the virion envelope |
| Q57278728 | Control of primary mouse cytomegalovirus infection in lung nodular inflammatory foci by cooperation of interferon-gamma expressing CD4 and CD8 T cells |
| Q40515663 | Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H. |
| Q43409130 | Cytomegaloviral hypophysitis in a simian immunodeficiency virus-infected rhesus macaque (Macacca mulatta). |
| Q35917480 | Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy |
| Q54590747 | Cytomegalovirus infection in patients with ulcerative colitis diagnosed by quantitative real-time PCR analysis. |
| Q26771385 | Cytomegalovirus infection in the bone marrow transplant patient |
| Q44553736 | Detection of multiple human herpes viruses by DNA microarray technology |
| Q41472299 | Diagnosing cytomegalovirus in patients with inflammatory bowel disease--by immunohistochemistry or polymerase chain reaction? |
| Q40321837 | Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2. |
| Q37875379 | Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives |
| Q39953959 | Efficient inhibition of human cytomegalovirus DNA polymerase expression by small hairpin RNA in vitro |
| Q37018933 | Efficient replication of rhesus cytomegalovirus variants in multiple rhesus and human cell types |
| Q35964751 | Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection |
| Q43407035 | Evidence that the human cytomegalovirus 46-kDa UL72 protein is not an active dUTPase but a late protein dispensable for replication in fibroblasts |
| Q40261325 | Experimental confirmation of global murine cytomegalovirus open reading frames by transcriptional detection and partial characterization of newly described gene products |
| Q90656099 | Expression of CMV protein pp65 in cutaneous malignant melanoma |
| Q42687124 | Full genome sequencing and analysis of human cytomegalovirus strain JHC isolated from a Korean patient |
| Q37149865 | Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV) |
| Q33311454 | Functional genetic analysis of rhesus cytomegalovirus: Rh01 is an epithelial cell tropism factor |
| Q37074285 | Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells |
| Q92154266 | HCMV Infection in a Mesenchymal Stem Cell Niche: Differential Impact on the Development of NK Cells versus ILC3 |
| Q36893722 | HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors |
| Q91656210 | Herpes virus infections |
| Q36107779 | Herpesviruses in periodontal diseases |
| Q40653356 | Host protein Snapin interacts with human cytomegalovirus pUL130 and affects viral DNA replication |
| Q33649006 | Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions |
| Q38779846 | Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art. |
| Q34301880 | Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion |
| Q36974741 | Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans |
| Q51976108 | Human cytomegalovirus immediate-early-gene expression disrupts embryogenesis in transgenic Drosophila. |
| Q38963623 | Human cytomegalovirus infection and vascular disease risk: A meta-analysis |
| Q42378308 | Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells |
| Q34669797 | Human cytomegalovirus infection is associated with essential hypertension in Kazakh and Han Chinese populations |
| Q40081891 | Human cytomegalovirus prevalence and distribution of glycoprotein B, O genotypes among hospitalized children with respiratory infections in West China, 2009-2014. |
| Q34922240 | Human cytomegalovirus resistance to deoxyribosylindole nucleosides maps to a transversion mutation in the terminase subunit-encoding gene UL89. |
| Q40584504 | Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication. |
| Q34277652 | Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade |
| Q40211244 | Human cytomegalovirus triggers the assembly of AIM2 inflammasome in THP-1-derived macrophages. |
| Q47605886 | Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy |
| Q46723963 | Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action |
| Q40242055 | Identification and classification of human cytomegalovirus capsids in textured electron micrographs using deformed template matching |
| Q40375876 | Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus |
| Q37566700 | Identification of cellular proteins that interact with human cytomegalovirus immediate-early protein 1 by protein array assay |
| Q43849501 | Immune evasion and the evolution of molecular mimicry in parasites |
| Q37538280 | Immunostaining Detection of Cytomegalovirus in Gastrointestinal Biopsies: Clinicopathological Correlation at a Large Academic Health System |
| Q33857275 | In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication |
| Q36208168 | Inactivation of the Human Cytomegalovirus US20 Gene Hampers Productive Viral Replication in Endothelial Cells |
| Q37410691 | Induction of therapeutic antibodies by vaccination against external loops of tumor-associated viral latent membrane protein |
| Q92072194 | Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies |
| Q37655207 | Interaction between HCMV pUL83 and human AIM2 disrupts the activation of the AIM2 inflammasome |
| Q48263611 | Is Pulmonary non-Tuberculous Mycobacterial Disease Linked with a High Burden of Latent Cytomegalovirus? |
| Q48487752 | Lack of association of herpesviruses with brain tumors |
| Q38711117 | Loss of the Human Cytomegalovirus US16 Protein Abrogates Virus Entry into Endothelial and Epithelial Cells by Reducing the Virion Content of the Pentamer. |
| Q34045330 | Mechanism of curcumin resistance to human cytomegalovirus in HELF cells |
| Q41918077 | Mechanisms of human cytomegalovirus infection with a focus on epidermal growth factor receptor interactions |
| Q39025231 | Metabolism of cyclopropavir and ganciclovir in human cytomegalovirus-infected cells |
| Q35158385 | Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors |
| Q34455464 | Molecular investigation of the 7.2 kb RNA of murine cytomegalovirus |
| Q33311453 | Multiplex detection of human herpesviruses from archival specimens by using matrix-assisted laser desorption ionization-time of flight mass spectrometry |
| Q40702950 | Multipotent mesenchymal stromal cells are fully permissive for human cytomegalovirus infection |
| Q63952478 | Myeloid Cells Restrict MCMV and Drive Stress-Induced Extramedullary Hematopoiesis through STAT1 |
| Q30433546 | NK gene complex and chromosome 19 loci enhance MHC resistance to murine cytomegalovirus infection |
| Q35160692 | National serosurvey of cytomegalovirus in Australia |
| Q91708029 | Natural Killer Cell-Derived IL-10 Prevents Liver Damage During Sustained Murine Cytomegalovirus Infection |
| Q52691329 | New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection. |
| Q40594795 | Perinuclear localization of Na-K-Cl-cotransporter protein after human cytomegalovirus infection |
| Q42098721 | Phase-dependent immune evasion of herpesviruses |
| Q40027571 | Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry. |
| Q36694825 | Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus. |
| Q34974085 | ProMiR II: a web server for the probabilistic prediction of clustered, nonclustered, conserved and nonconserved microRNAs |
| Q34349745 | Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases |
| Q34495529 | Reverse genetics modification of cytomegalovirus antigenicity and immunogenicity by CD8 T-cell epitope deletion and insertion |
| Q54530574 | Reverse transcriptase-polymerase chain reaction to evaluate human cytomegalovirus lytic gene expression. |
| Q37350364 | Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus |
| Q36185784 | RhoB is a component of the human cytomegalovirus assembly complex and is required for efficient viral production. |
| Q24537618 | Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet |
| Q36083783 | Seroprevalence and Influence of Torch Infections in High Risk Pregnant Women: A Large Study from South India |
| Q36172022 | Sociodemographic factors associated with IgG and IgM seroprevalence for human cytomegalovirus infection in adult populations of Pakistan: a seroprevalence survey. |
| Q82858263 | The Elk-1 and serum response factor binding sites in the major immediate-early promoter of human cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NF-kappaB sites in proliferating |
| Q40331128 | The Major Immediate-Early Protein IE2 of Human Cytomegalovirus Is Sufficient to Induce Proteasomal Degradation of CD83 on Mature Dendritic Cells |
| Q93118202 | The Susceptibility of Primary Dermis Fibroblasts from the Chinese Tree Shrew to Human Cytomegalovirus Infection |
| Q36086685 | The US16 gene of human cytomegalovirus is required for efficient viral infection of endothelial and epithelial cells |
| Q24623318 | The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice |
| Q40311059 | The expression of p16INK4a tumor suppressor is upregulated by human cytomegalovirus infection and required for optimal viral replication. |
| Q40322816 | The human cytomegalovirus-encoded receptor US28 increases the activity of the major immediate-early promoter/enhancer |
| Q38547042 | The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients |
| Q36000428 | The immunoregulatory effects of CMV-infection in human fibroblasts and the impact on cellular senescence. |
| Q44352400 | The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection |
| Q24304029 | The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication |
| Q35363103 | The latency-associated UL138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF-alpha) signaling by upregulating TNF-alpha receptor 1 cell surface expression. |
| Q40700515 | The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis |
| Q37296023 | The susceptibility of primary cultured rhesus macaque kidney epithelial cells to rhesus cytomegalovirus strains. |
| Q35469047 | Transcriptional activation of endoplasmic reticulum chaperone GRP78 by HCMV IE1-72 protein |
| Q36884194 | Translational mini-review series on infectious disease: congenital cytomegalovirus infection: 50 years on. |
| Q37174468 | Two Polypyrimidine Tracts in Intron 4 of the Major Immediate Early Gene Are Critical for Gene Expression Switching from IE1 to IE2 and for Replication of Human Cytomegalovirus |
| Q35354212 | Ubiquitin-independent proteasomal degradation during oncogenic viral infections |
| Q27487313 | Viruses as co-factors for the initiation or exacerbation of lung fibrosis |
| Q36177685 | Viruses in periodontal disease - a review |
Search more.